DTx East
There are many stakeholders interested in digital therapeutics, but aligning under the common goal of patient needs is key.
Panelists at DTx East discuss the journey to implementing digital therapeutics into pharma and say more partnerships are likely.
Panelists at DTx East discuss the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold.
At DTx in Boston representatives of major pharma companies discussed opportunies of working with digital theraputics companies and what they wish the startups knew.